APO Research
Talk to an analyst

APO RESEARCH · REPORT

Insulin Syringes

Insulin syringes are small-capacity syringe systems with graduations configured for a specified insulin concentration and commonly an integrated fine needle.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Unit graduations are tied to the specified concentration; they are not universal volume labels. Device comparison must retain that concentration and graduation relationship.

What turns activity into demand

Device demand is defined by container or delivery function, connection, materials and validated manufacturing. Prefilling adds formulation compatibility and storage integrity to the device boundary.

The commercial boundary

Injection, enteral, oral and analytical devices have different interfaces and intended uses. Representative images establish neither sterility nor clinical suitability.

Which concentration does the graduation scale assume?

Unit graduations are tied to the specified concentration; they are not universal volume labels. Device comparison must retain that concentration and graduation relationship.

Technical reading

Selected research

Industry Research

Insulin Syringes Industry Research Report 2026

22 December 2025138 pages

Choose your research edition.

Industry ResearchInsulin Syringes Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Syringes Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Insulin Syringes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Syringes Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Syringes Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Insulin Syringes market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Insulin Syringes is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Insulin Syringes is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Insulin Syringes is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Insulin Syringes include Sanofi, Novo Nordisk, Eli Lilly and Company, Ypsomed AG, Wockhardt Ltd, Terumo Corporation, Nipro Medical Corporation, Medtronic Plc and Medline Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Insulin Syringes market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Insulin Syringes Market by Company

Sanofi

Novo Nordisk

Eli Lilly and Company

Ypsomed AG

Wockhardt Ltd

Terumo Corporation

Nipro Medical Corporation

Medtronic Plc

Medline Industries

HMD Healthcare Ltd

F. Hoffmann-La Roche

Cardinal Health Inc

Braun Melunsun

Biocon Ltd

BD

Animas Corporation

Abbott Laboratories

Insulin Syringes Segment by Type

1/2 CC Syringe

1 CC Syringe

3/10 CC Syringe

Others

Insulin Syringes Segment by Application

Hospital

Homecare

Others

Insulin Syringes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Syringes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Syringes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Syringes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Insulin Syringes manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Insulin Syringes by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Insulin Syringes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Insulin Syringes Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Insulin Syringes Sales (k units) of Manufacturers (2021-2026) Table 7. Global Insulin Syringes Sales Market Share by Manufacturers (2021-2026) Table 8. Global Insulin Syringes Revenue of Manufacturers (2021-2026) Table 9. Global Insulin Syringes Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Insulin Syringes Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Insulin Syringes Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Insulin Syringes, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Insulin Syringes, Product Type & Application Table 14. Global Insulin Syringes Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Insulin Syringes by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Sanofi Company Information Table 19. Sanofi Business Overview Table 20. Sanofi Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Sanofi Insulin Syringes Product Portfolio Table 22. Sanofi Recent Developments Table 23. Novo Nordisk Company Information Table 24. Novo Nordisk Business Overview Table 25. Novo Nordisk Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Novo Nordisk Insulin Syringes Product Portfolio Table 27. Novo Nordisk Recent Developments Table 28. Eli Lilly and Company Company Information Table 29. Eli Lilly and Company Business Overview Table 30. Eli Lilly and Company Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Eli Lilly and Company Insulin Syringes Product Portfolio Table 32. Eli Lilly and Company Recent Developments Table 33. Ypsomed AG Company Information Table 34. Ypsomed AG Business Overview Table 35. Ypsomed AG Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Ypsomed AG Insulin Syringes Product Portfolio Table 37. Ypsomed AG Recent Developments Table 38. Wockhardt Ltd Company Information Table 39. Wockhardt Ltd Business Overview Table 40. Wockhardt Ltd Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Wockhardt Ltd Insulin Syringes Product Portfolio Table 42. Wockhardt Ltd Recent Developments Table 43. Terumo Corporation Company Information Table 44. Terumo Corporation Business Overview Table 45. Terumo Corporation Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Terumo Corporation Insulin Syringes Product Portfolio Table 47. Terumo Corporation Recent Developments Table 48. Nipro Medical Corporation Company Information Table 49. Nipro Medical Corporation Business Overview Table 50. Nipro Medical Corporation Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Nipro Medical Corporation Insulin Syringes Product Portfolio Table 52. Nipro Medical Corporation Recent Developments Table 53. Medtronic Plc Company Information Table 54. Medtronic Plc Business Overview Table 55. Medtronic Plc Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Medtronic Plc Insulin Syringes Product Portfolio Table 57. Medtronic Plc Recent Developments Table 58. Medline Industries Company Information Table 59. Medline Industries Business Overview Table 60. Medline Industries Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Medline Industries Insulin Syringes Product Portfolio Table 62. Medline Industries Recent Developments Table 63. HMD Healthcare Ltd Company Information Table 64. HMD Healthcare Ltd Business Overview Table 65. HMD Healthcare Ltd Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. HMD Healthcare Ltd Insulin Syringes Product Portfolio Table 67. HMD Healthcare Ltd Recent Developments Table 68. F. Hoffmann-La Roche Company Information Table 69. F. Hoffmann-La Roche Business Overview Table 70. F. Hoffmann-La Roche Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. F. Hoffmann-La Roche Insulin Syringes Product Portfolio Table 72. F. Hoffmann-La Roche Recent Developments Table 73. Cardinal Health Inc Company Information Table 74. Cardinal Health Inc Business Overview Table 75. Cardinal Health Inc Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Cardinal Health Inc Insulin Syringes Product Portfolio Table 77. Cardinal Health Inc Recent Developments Table 78. Braun Melunsun Company Information Table 79. Braun Melunsun Business Overview Table 80. Braun Melunsun Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Braun Melunsun Insulin Syringes Product Portfolio Table 82. Braun Melunsun Recent Developments Table 83. Biocon Ltd Company Information Table 84. Biocon Ltd Business Overview Table 85. Biocon Ltd Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Biocon Ltd Insulin Syringes Product Portfolio Table 87. Biocon Ltd Recent Developments Table 88. BD Company Information Table 89. BD Business Overview Table 90. BD Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. BD Insulin Syringes Product Portfolio Table 92. BD Recent Developments Table 93. Animas Corporation Company Information Table 94. Animas Corporation Business Overview Table 95. Animas Corporation Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Animas Corporation Insulin Syringes Product Portfolio Table 97. Animas Corporation Recent Developments Table 98. Abbott Laboratories Company Information Table 99. Abbott Laboratories Business Overview Table 100. Abbott Laboratories Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Abbott Laboratories Insulin Syringes Product Portfolio Table 102. Abbott Laboratories Recent Developments Table 103. Global Insulin Syringes Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Insulin Syringes Sales by Region (2021-2026) & (k units) Table 105. Global Insulin Syringes Sales Market Share by Region (2021-2026) Table 106. Global Insulin Syringes Sales by Region (2027-2032) & (k units) Table 107. Global Insulin Syringes Sales Market Share by Region (2027-2032) Table 108. Global Insulin Syringes Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Insulin Syringes Revenue Market Share by Region (2021-2026) Table 110. Global Insulin Syringes Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Insulin Syringes Revenue Market Share by Region (2027-2032) Table 112. North America Insulin Syringes Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Insulin Syringes Sales by Country (2021-2026) & (k units) Table 114. North America Insulin Syringes Sales by Country (2027-2032) & (k units) Table 115. North America Insulin Syringes Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Insulin Syringes Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Insulin Syringes Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Insulin Syringes Sales by Country (2021-2026) & (k units) Table 119. Europe Insulin Syringes Sales by Country (2027-2032) & (k units) Table 120. Europe Insulin Syringes Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Insulin Syringes Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Insulin Syringes Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Insulin Syringes Sales by Country (2021-2026) & (k units) Table 124. Asia Pacific Insulin Syringes Sales by Country (2027-2032) & (k units) Table 125. Asia Pacific Insulin Syringes Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Insulin Syringes Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Insulin Syringes Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Insulin Syringes Sales by Country (2021-2026) & (k units) Table 129. South America Insulin Syringes Sales by Country (2027-2032) & (k units) Table 130. South America Insulin Syringes Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Insulin Syringes Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Insulin Syringes Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Insulin Syringes Sales by Country (2021-2026) & (k units) Table 134. Middle East and Africa Insulin Syringes Sales by Country (2027-2032) & (k units) Table 135. Middle East and Africa Insulin Syringes Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Insulin Syringes Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Insulin Syringes Sales by Type (2021-2026) & (k units) Table 138. Global Insulin Syringes Sales by Type (2027-2032) & (k units) Table 139. Global Insulin Syringes Sales Market Share by Type (2021-2026) Table 140. Global Insulin Syringes Sales Market Share by Type (2027-2032) Table 141. Global Insulin Syringes Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Insulin Syringes Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Insulin Syringes Revenue Market Share by Type (2021-2026) Table 144. Global Insulin Syringes Revenue Market Share by Type (2027-2032) Table 145. Global Insulin Syringes Price by Type (2021-2026) & (US$/unit) Table 146. Global Insulin Syringes Price by Type (2027-2032) & (US$/unit) Table 147. Global Insulin Syringes Sales by Application (2021-2026) & (k units) Table 148. Global Insulin Syringes Sales by Application (2027-2032) & (k units) Table 149. Global Insulin Syringes Sales Market Share by Application (2021-2026) Table 150. Global Insulin Syringes Sales Market Share by Application (2027-2032) Table 151. Global Insulin Syringes Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Insulin Syringes Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Insulin Syringes Revenue Market Share by Application (2021-2026) Table 154. Global Insulin Syringes Revenue Market Share by Application (2027-2032) Table 155. Global Insulin Syringes Price by Application (2021-2026) & (US$/unit) Table 156. Global Insulin Syringes Price by Application (2027-2032) & (US$/unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Insulin Syringes Distributors List Table 160. Insulin Syringes Customers List Table 161. Insulin Syringes Industry Trends Table 162. Insulin Syringes Industry Drivers Table 163. Insulin Syringes Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Insulin Syringes Product Image Figure 5. Global Insulin Syringes Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Insulin Syringes Market Size (2021-2032) & (US$ Million) Figure 7. Global Insulin Syringes Sales (2021-2032) & (k units) Figure 8. Global Insulin Syringes Average Price (US$/unit) & (2021-2032) Figure 9. 1/2 CC Syringe Product Image Figure 10. 1 CC Syringe Product Image Figure 11. 3/10 CC Syringe Product Image Figure 12. Others Product Image Figure 13. Hospital Product Image Figure 14. Homecare Product Image Figure 15. Others Product Image Figure 16. Global Insulin Syringes Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Insulin Syringes, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Insulin Syringes Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Insulin Syringes Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Insulin Syringes Sales by Region in 2025 Figure 22. Global Insulin Syringes Revenue by Region in 2025 Figure 23. North America Insulin Syringes Market Size by Country in 2025 Figure 24. North America Insulin Syringes Sales Market Share by Country (2021-2032) Figure 25. North America Insulin Syringes Revenue Market Share by Country (2021-2032) Figure 26. United States Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Insulin Syringes Market Size by Country in 2025 Figure 30. Europe Insulin Syringes Sales Market Share by Country (2021-2032) Figure 31. Europe Insulin Syringes Revenue Market Share by Country (2021-2032) Figure 32. Germany Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Insulin Syringes Market Size by Country in 2025 Figure 43. Asia Pacific Insulin Syringes Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Insulin Syringes Revenue Market Share by Country (2021-2032) Figure 45. China Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Insulin Syringes Market Size by Country in 2025 Figure 54. South America Insulin Syringes Sales Market Share by Country (2021-2032) Figure 55. South America Insulin Syringes Revenue Market Share by Country (2021-2032) Figure 56. Brazil Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Insulin Syringes Market Size by Country in 2025 Figure 60. Middle East and Africa Insulin Syringes Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Insulin Syringes Revenue Market Share by Country (2021-2032) Figure 62. Egypt Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Insulin Syringes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Insulin Syringes Sales Market Share by Type (2021-2032) Figure 68. Global Insulin Syringes Revenue Market Share by Type (2021-2032) Figure 69. Global Insulin Syringes Price (US$/unit) by Type (2021-2032) Figure 70. Global Insulin Syringes Sales Market Share by Application (2021-2032) Figure 71. Global Insulin Syringes Revenue Market Share by Application (2021-2032) Figure 72. Global Insulin Syringes Price (US$/unit) by Application (2021-2032) Figure 73. Insulin Syringes Value Chain Figure 74. Insulin Syringes Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Insulin Syringes Industry Opportunities and Challenges

Scope & coverage.

Types
  • 1/2 CC Syringe
  • 1 CC Syringe
  • 3/10 CC Syringe
  • Others
Applications
  • Hospital
  • Homecare
  • Others
Companies covered
  • Sanofi
  • Novo Nordisk
  • Eli Lilly and Company
  • Ypsomed AG
  • Wockhardt Ltd
  • Terumo Corporation
  • Nipro Medical Corporation
  • Medtronic Plc
  • Medline Industries
  • HMD Healthcare Ltd
  • F. Hoffmann-La Roche
  • Cardinal Health Inc
  • Braun Melunsun
  • Biocon Ltd
  • BD
  • Animas Corporation
  • Abbott Laboratories

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Insulin Syringes Market Size (2021-2032)
  4. 2.2.2 Global Insulin Syringes Sales (2021-2032)
  5. 2.2.3 Global Insulin Syringes Market Average Price (2021-2032)
  6. 2.3 Insulin Syringes by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 1/2 CC Syringe
  9. 2.3.3 1 CC Syringe
  10. 2.3.4 3/10 CC Syringe
  11. 2.3.5 Others
  12. 2.4 Insulin Syringes by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Hospital
  15. 2.4.3 Homecare
  16. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Insulin Syringes Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Insulin Syringes Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Insulin Syringes Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Insulin Syringes Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Insulin Syringes Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Insulin Syringes, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Insulin Syringes, Product Type & Application
  8. 3.8 Global Manufacturers of Insulin Syringes, Established Date
  9. 3.9 Global Insulin Syringes Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Sanofi
  2. 4.1.1 Sanofi Company Information
  3. 4.1.2 Sanofi Business Overview
  4. 4.1.3 Sanofi Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Sanofi Insulin Syringes Product Portfolio
  6. 4.1.5 Sanofi Recent Developments
  7. 4.2 Novo Nordisk
  8. 4.2.1 Novo Nordisk Company Information
  9. 4.2.2 Novo Nordisk Business Overview
  10. 4.2.3 Novo Nordisk Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Novo Nordisk Insulin Syringes Product Portfolio
  12. 4.2.5 Novo Nordisk Recent Developments
  13. 4.3 Eli Lilly and Company
  14. 4.3.1 Eli Lilly and Company Company Information
  15. 4.3.2 Eli Lilly and Company Business Overview
  16. 4.3.3 Eli Lilly and Company Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Eli Lilly and Company Insulin Syringes Product Portfolio
  18. 4.3.5 Eli Lilly and Company Recent Developments
  19. 4.4 Ypsomed AG
  20. 4.4.1 Ypsomed AG Company Information
  21. 4.4.2 Ypsomed AG Business Overview
  22. 4.4.3 Ypsomed AG Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Ypsomed AG Insulin Syringes Product Portfolio
  24. 4.4.5 Ypsomed AG Recent Developments
  25. 4.5 Wockhardt Ltd
  26. 4.5.1 Wockhardt Ltd Company Information
  27. 4.5.2 Wockhardt Ltd Business Overview
  28. 4.5.3 Wockhardt Ltd Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Wockhardt Ltd Insulin Syringes Product Portfolio
  30. 4.5.5 Wockhardt Ltd Recent Developments
  31. 4.6 Terumo Corporation
  32. 4.6.1 Terumo Corporation Company Information
  33. 4.6.2 Terumo Corporation Business Overview
  34. 4.6.3 Terumo Corporation Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Terumo Corporation Insulin Syringes Product Portfolio
  36. 4.6.5 Terumo Corporation Recent Developments
  37. 4.7 Nipro Medical Corporation
  38. 4.7.1 Nipro Medical Corporation Company Information
  39. 4.7.2 Nipro Medical Corporation Business Overview
  40. 4.7.3 Nipro Medical Corporation Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Nipro Medical Corporation Insulin Syringes Product Portfolio
  42. 4.7.5 Nipro Medical Corporation Recent Developments
  43. 4.8 Medtronic Plc
  44. 4.8.1 Medtronic Plc Company Information
  45. 4.8.2 Medtronic Plc Business Overview
  46. 4.8.3 Medtronic Plc Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Medtronic Plc Insulin Syringes Product Portfolio
  48. 4.8.5 Medtronic Plc Recent Developments
  49. 4.9 Medline Industries
  50. 4.9.1 Medline Industries Company Information
  51. 4.9.2 Medline Industries Business Overview
  52. 4.9.3 Medline Industries Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Medline Industries Insulin Syringes Product Portfolio
  54. 4.9.5 Medline Industries Recent Developments
  55. 4.10 HMD Healthcare Ltd
  56. 4.10.1 HMD Healthcare Ltd Company Information
  57. 4.10.2 HMD Healthcare Ltd Business Overview
  58. 4.10.3 HMD Healthcare Ltd Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 HMD Healthcare Ltd Insulin Syringes Product Portfolio
  60. 4.10.5 HMD Healthcare Ltd Recent Developments
  61. 4.11 F. Hoffmann-La Roche
  62. 4.11.1 F. Hoffmann-La Roche Company Information
  63. 4.11.2 F. Hoffmann-La Roche Business Overview
  64. 4.11.3 F. Hoffmann-La Roche Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 F. Hoffmann-La Roche Insulin Syringes Product Portfolio
  66. 4.11.5 F. Hoffmann-La Roche Recent Developments
  67. 4.12 Cardinal Health Inc
  68. 4.12.1 Cardinal Health Inc Company Information
  69. 4.12.2 Cardinal Health Inc Business Overview
  70. 4.12.3 Cardinal Health Inc Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Cardinal Health Inc Insulin Syringes Product Portfolio
  72. 4.12.5 Cardinal Health Inc Recent Developments
  73. 4.13 Braun Melunsun
  74. 4.13.1 Braun Melunsun Company Information
  75. 4.13.2 Braun Melunsun Business Overview
  76. 4.13.3 Braun Melunsun Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Braun Melunsun Insulin Syringes Product Portfolio
  78. 4.13.5 Braun Melunsun Recent Developments
  79. 4.14 Biocon Ltd
  80. 4.14.1 Biocon Ltd Company Information
  81. 4.14.2 Biocon Ltd Business Overview
  82. 4.14.3 Biocon Ltd Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Biocon Ltd Insulin Syringes Product Portfolio
  84. 4.14.5 Biocon Ltd Recent Developments
  85. 4.15 BD
  86. 4.15.1 BD Company Information
  87. 4.15.2 BD Business Overview
  88. 4.15.3 BD Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 BD Insulin Syringes Product Portfolio
  90. 4.15.5 BD Recent Developments
  91. 4.16 Animas Corporation
  92. 4.16.1 Animas Corporation Company Information
  93. 4.16.2 Animas Corporation Business Overview
  94. 4.16.3 Animas Corporation Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Animas Corporation Insulin Syringes Product Portfolio
  96. 4.16.5 Animas Corporation Recent Developments
  97. 4.17 Abbott Laboratories
  98. 4.17.1 Abbott Laboratories Company Information
  99. 4.17.2 Abbott Laboratories Business Overview
  100. 4.17.3 Abbott Laboratories Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Abbott Laboratories Insulin Syringes Product Portfolio
  102. 4.17.5 Abbott Laboratories Recent Developments
5 Global Insulin Syringes Market Scenario by Region
  1. 5.1 Global Insulin Syringes Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Insulin Syringes Sales by Region: 2021-2032
  3. 5.2.1 Global Insulin Syringes Sales by Region: 2021-2026
  4. 5.2.2 Global Insulin Syringes Sales by Region: 2027-2032
  5. 5.3 Global Insulin Syringes Revenue by Region: 2021-2032
  6. 5.3.1 Global Insulin Syringes Revenue by Region: 2021-2026
  7. 5.3.2 Global Insulin Syringes Revenue by Region: 2027-2032
  8. 5.4 North America Insulin Syringes Market Facts & Figures by Country
  9. 5.4.1 North America Insulin Syringes Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Insulin Syringes Sales by Country (2021-2032)
  11. 5.4.3 North America Insulin Syringes Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Insulin Syringes Market Facts & Figures by Country
  16. 5.5.1 Europe Insulin Syringes Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Insulin Syringes Sales by Country (2021-2032)
  18. 5.5.3 Europe Insulin Syringes Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Insulin Syringes Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Insulin Syringes Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Insulin Syringes Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Insulin Syringes Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Insulin Syringes Market Facts & Figures by Country
  41. 5.7.1 South America Insulin Syringes Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Insulin Syringes Sales by Country (2021-2032)
  43. 5.7.3 South America Insulin Syringes Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Insulin Syringes Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Insulin Syringes Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Insulin Syringes Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Insulin Syringes Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Insulin Syringes Sales by Type (2021-2032)
  2. 6.1.1 Global Insulin Syringes Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Insulin Syringes Sales Market Share by Type (2021-2032)
  4. 6.2 Global Insulin Syringes Revenue by Type (2021-2032)
  5. 6.2.1 Global Insulin Syringes Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Insulin Syringes Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Insulin Syringes Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Insulin Syringes Sales by Application (2021-2032)
  2. 7.1.1 Global Insulin Syringes Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Insulin Syringes Sales Market Share by Application (2021-2032)
  4. 7.2 Global Insulin Syringes Revenue by Application (2021-2032)
  5. 7.2.1 Global Insulin Syringes Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Insulin Syringes Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Insulin Syringes Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Insulin Syringes Value Chain Analysis
  2. 8.1.1 Insulin Syringes Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Insulin Syringes Production Mode & Process
  5. 8.2 Insulin Syringes Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Insulin Syringes Distributors
  8. 8.2.3 Insulin Syringes Customers
9 Global Insulin Syringes Analyzing Market Dynamics
  1. 9.1 Insulin Syringes Industry Trends
  2. 9.2 Insulin Syringes Industry Drivers
  3. 9.3 Insulin Syringes Industry Opportunities and Challenges
  4. 9.4 Insulin Syringes Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst